Akero Therapeutics Inc
(AKRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,331 | -53,344 | -151,759 | -96,573 | -56,914 |
| Depreciation Amortization | -6,098 | -2,809 | -9,077 | -5,553 | -2,405 |
| Accounts payable and accrued liabilities | 7,549 | 6,456 | -645 | 3,584 | 2,245 |
| Other Working Capital | 6,191 | 13,075 | -6,670 | -10,598 | 2,114 |
| Other Operating Activity | 9,096 | 1,482 | 22,784 | 12,400 | 7,939 |
| Operating Cash Flow | $-92,593 | $-35,140 | $-145,367 | $-96,740 | $-47,021 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -197,048 | 57,849 | -223,623 | 138,500 | -110,712 |
| PPE Investments | N/A | N/A | N/A | -374,909 | N/A |
| Other Investing Activity | -999 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-198,047 | $57,849 | $-223,623 | $-236,409 | $-110,712 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 15,000 | 15,000 | 15,000 |
| Common Stock Issued | 357,539 | 357,212 | 339,092 | 338,559 | 337,753 |
| Other Financing Activity | -751 | -274 | -776 | -745 | -745 |
| Financing Cash Flow | $366,788 | $366,938 | $353,316 | $352,814 | $352,008 |
| Beginning Cash Position | 234,207 | 234,207 | 249,881 | 249,881 | 249,881 |
| End Cash Position | 310,355 | 623,854 | 234,207 | 269,546 | 444,156 |
| Net Cash Flow | $76,148 | $389,647 | $-15,674 | $19,665 | $194,275 |
| Free Cash Flow | |||||
| Operating Cash Flow | -92,593 | -35,140 | -145,367 | -96,740 | -47,021 |
| Capital Expenditure | N/A | N/A | N/A | -374,909 | N/A |
| Free Cash Flow | -92,593 | -35,140 | -145,367 | -471,649 | -47,021 |